Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Low-Carb app help control diabetes?

NCT ID NCT04916314

Disease control Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a 12-week low-carbohydrate diet program, delivered through a smartphone app with remote coaching, could help people with type 2 diabetes improve their blood sugar and lose weight. 115 adults recently diagnosed with type 2 diabetes and who were overweight took part. The program included meal plans, peer support, and activity tracking. Researchers measured changes in blood sugar and weight at 3 months and 1 year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Low carbohydrate diet
What this could lead to
If it works, this could offer a practical, app-based way for people with type 2 diabetes to improve blood sugar control and possibly achieve remission.
What could go wrong
This is a small, completed trial with only 115 participants. Results may not apply to everyone, and sticking to a low-carb diet long-term can be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

115 people

The number who actually took part.

Started

Jul 2021

Finished

Oct 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged 40 years or above. * Diagnosed with current type 2 diabetes (i.e. not in remission) in the last 6 years * BMI of ≥27kg/m2 (≥30kg/m2 if ethnicity recorded as white) * Has a smartphone or computer with internet access (and the correct operating system requirements to use the intervention programme) * Are able to complete the eligibility and baseline assessments online * Would like to make changes to their diet or lifestyle to improve their diabetes control, lose weight, or improve their general health Exclusion Criteria: * Unable to understand the study materials and interventions * Currently following a weight loss programme (defined as a structured, prescribed and monitored programme and not a self-directed weight loss attempt) * Pregnant, breastfeeding, or planning to become pregnant during the course of the study * History of bariatric surgery, including gastric banding * Currently using insulin therapy * Proliferative diabetic retinopathy, or maculopathy. * Recent myocardial infarction or stroke (\<3 months) * Renal failure (chronic kidney disease stage 4 or 5) * Current active treatment for cancer (other than skin cancer treated with curative intent by local treatment only) * Their doctor does not feel they are appropriate to participate for another reason (e.g. active eating disorder diagnosis, significant psychological disturbance)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes mellitus in obese are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes mellitus in obese

Contacts and locations

Locations

  • University of Oxford

    Warwick, Select A Region, CV34 4NH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.